Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Core EBITDA Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 35.7080.69186.95-48.932.87

What is the latest Core EBITDA Growth ratio of NATCO PHARMA ?

The latest Core EBITDA Growth ratio of NATCO PHARMA is 35.70 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202535.70
Mar202480.69
Mar2023186.95
Mar2022-48.93
Mar20212.87

How is Core EBITDA Growth of NATCO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 35.7
-55.76
Mar2024 80.69
-56.84
Mar2023 186.95
Positive
Mar2022 -48.93
Negative
Mar2021 2.87 -

Other Financial Ratios of NATCO PHARMA


Compare Core EBITDA Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,458.4 Cr -8.6% 9.4% -38.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,536.0 Cr -1.8% 4.1% -1.6% Stock Analytics
DIVIS LABORATORIES ₹170,753.0 Cr -2.8% -3.7% 2.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,650.0 Cr -0.2% -0.9% 12.9% Stock Analytics
CIPLA ₹122,143.0 Cr -2.1% -1.7% 0.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,244.0 Cr -2% 3.3% -0.6% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-8.6%

9.4%

-38.5%

SENSEX

-0.5%

1.1%

3.8%


You may also like the below Video Courses